06.03.2021
Improve Outcomes
$2,618,719.00
42 months
Molecular Design and Testing of Glucose-Responsive Therapies
To develop and evaluate novel glucose responsive insulin analogs and glucagon-insulin fusion proteins to improve glucose control for people with T1D